EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Regulatory role of CD39 and CD73 in tumor immunity

Nicole Kaplinsky, Kada Williams, Dean Watkins iD, Molly Adams, Laura Stanbery, John Nemunaitis iD

Future Oncology · 14.06.2024 · 20 (19) · 1367-1380

DOI: 10.2217/fon-2023-0871 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Future Oncology, online erschienen am 23.04.2024. Verfasst von Nicole Kaplinsky und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of Toledo College of Medicine, Toledo, OH 43614, USA. Hauptthemen laut MEDLINE: 5'-Nucleotidase, Apyrase, Neoplasms, Tumor Microenvironment. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CD39 is the rate-limiting enzyme for the molecular signal cascade leading to the generation of ADP and adenosine monophosphate (AMP). In conjunction with CD73, CD39 converts adenosine triphosphate (ATP) to ADP and AMP, which leads to the accumulation of immunosuppressive adenosine in the tumor microenvironment. This review focuses on the role of CD39 and CD73 in immune response and malignant progression, including the expression of CD39 within the tumor microenvironment and its relationship to immune effector cells, and its role in antigen presentation. The role of CD39- and CD73-targeting therapeutics and cancer-directed clinical trials investigating CD39 modulation are also explored. [Box: see text].

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

5'-NucleotidaseApyraseNeoplasmsTumor MicroenvironmentHumansAnimalsGPI-Linked ProteinsAntigens, CDAntigen Presentation

Stichwörter der Autor:innen

CD39CD73ENTPD1adenosine pathwayantigenimmunotherapytumor microenvironment

Substanzen

5'-NucleotidaseApyraseNT5E protein, humanENTPD1 protein, humanGPI-Linked ProteinsAntigens, CDCD39 antigen

Autor:innen und Institutionen

  • University of Toledo College of Medicine, Toledo, OH 43614, USA.
  • Gradalis, Inc, Dallas, TX 75006, USA.

ORCID-Profile: Dean Watkins, John Nemunaitis

Zitieren

APA

Kaplinsky, N., Williams, K., Watkins, D., Adams, M., Stanbery, L., & Nemunaitis, J. (2024). Regulatory role of CD39 and CD73 in tumor immunity. Future Oncology, 20(19), 1367-1380. https://doi.org/10.2217/fon-2023-0871

Vancouver

Kaplinsky N, Williams K, Watkins D, Adams M, Stanbery L, Nemunaitis J. Regulatory role of CD39 and CD73 in tumor immunity. Future Oncology. 2024;20(19):1367-1380. doi:10.2217/fon-2023-0871

BibTeX
@article{Kaplinsky2024,
  author = {Kaplinsky, Nicole and Williams, Kada and Watkins, Dean and Adams, Molly and Stanbery, Laura and Nemunaitis, John},
  title = {Regulatory role of CD39 and CD73 in tumor immunity},
  journal = {Future Oncology},
  year = {2024},
  volume = {20},
  number = {19},
  pages = {1367--1380},
  doi = {10.2217/fon-2023-0871}
}
Kostenlos starten →